Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Delek US | DK | Nov 25, 2024 | 19.09 | +2.63 |
Dell Technologies C | DELL | Nov 25, 2024 | 144.16 | -0.03 |
Delta Air Lines | DAL | Nov 25, 2024 | 64.49 | +1.82 |
Deluxe | DLX | Nov 25, 2024 | 23.43 | +0.77 |
Denali Capital Acquisition A | DECA | Nov 25, 2024 | 11.71 | +0.17 |
Denali Capital Acquisition Unit | DECAU | Nov 25, 2024 | 11.60 | 0.00 |
Denali Therapeutics | DNLI | Nov 25, 2024 | 24.50 | -0.77 |
Denison Mines | DNN | Nov 25, 2024 | 2.32 | -2.93 |
Dennys | DENN | Nov 25, 2024 | 6.65 | +6.40 |
DENTSPLY SIRONA | XRAY | Nov 25, 2024 | 19.52 | +4.00 |
Dermata Therapeutics | DRMA | Nov 25, 2024 | 1.15 | +1.13 |
Descartes Systems Group | DSGX | Nov 25, 2024 | 117.25 | +1.01 |
Design Therapeutics | DSGN | Nov 25, 2024 | 5.62 | 0.00 |
Designer Brands A | DBI | Nov 25, 2024 | 5.52 | +9.52 |
Desktop Metal A | DM | Nov 25, 2024 | 4.16 | -5.88 |
Despegar.com | DESP | Nov 25, 2024 | 17.76 | -5.28 |
Destiny Tech100 | DXYZ | Nov 25, 2024 | 43.89 | +4.57 |
Destra Multialternative Fund | DMA | Nov 25, 2024 | 8.97 | +0.67 |
Deswell Industries | DSWL | Nov 25, 2024 | 2.70 | +2.91 |
Deutsche Bank | DB | Nov 25, 2024 | 16.48 | +1.73 |
Dev Mkts Ex-US Alphadex First Trust | FDT | Nov 25, 2024 | 55.88 | +0.05 |
Dev Mkts Ex-US SC Alphadex First Trust | FDTS | Nov 25, 2024 | 40.97 | -0.25 |
Devon Energy | DVN | Nov 25, 2024 | 38.27 | -2.99 |
DevvStream | DEVS | Nov 25, 2024 | 0.52 | 0.00 |
DexCom | DXCM | Nov 25, 2024 | 77.83 | +6.87 |
DHI Group | DHX | Nov 25, 2024 | 1.75 | +1.16 |
DHT | DHT | Nov 25, 2024 | 10.01 | -2.15 |
Diageo ADR | DEO | Nov 25, 2024 | 120.39 | +0.25 |
DiaMedica Therapeutics | DMAC | Nov 25, 2024 | 4.62 | -1.70 |
Diamond Hill Investment Group A | DHIL | Nov 25, 2024 | 169.40 | -0.68 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.